Offerings // InMed Pharmaceuticals Inc.

INM offering history

Every offering-related filing in InMed Pharmaceuticals Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 516 filings back to Jan 17, 2018.

Last executed offering

Apr 3, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Mar 20, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Oct 28, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 1, 2026	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 1, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 3, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 30, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 20, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 5, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 1, 2025	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Aug 1, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jul 9, 2025	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jun 30, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 2, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 31, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 30, 2024	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Dec 23, 2024	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Dec 18, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 17, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 28, 2024	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 13, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 13, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 8, 2023	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 30, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 15, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Dec 14, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 7, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Nov 22, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 19, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 18, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 12, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 7, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 14, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 6, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 29, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jun 24, 2022	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jun 21, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Jun 6, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)

INM offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full INM workspace →

INM offering FAQ

When did INM last execute an offering?

Per SEC filings, InMed Pharmaceuticals Inc.'s most recent priced offering document is a 424B5 filed 2026-04-03. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did INM last announce or register an offering?

The most recent registration is a S-3 filed 2026-03-20. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.